Athersys Inc (ATHXQ)

[CogDiss 1188X]

It seems like the Healios trials completing enrollment are the known events. The Japanese stroke trial (TREASURE) should complete enrollment by end of 2020, maybe slightly earlier (someone on Reddit suggests mid-November by reading Gil Vanbokken tea leaf comments). The Japanese ARDS trial with additional covid patients (ONE-BRIDGE) is listed on clinicaltrials.gov to complete in March, 2021. Healios has suggested they are essentially on schedule.

Unfortunately, I haven’t saved off the links to this. I watched a Healios investor presentation a few months ago but can’t find it now.

Athersys has suggested that they are in conversations with potential European pharmas to partner on various possibilities, especially the stroke indication. That’s the big kahuna that will shoot Athersys into the stratosphere if successful. It is my main focus with them, though earlier Healios results could be significant catalysts.